Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma
Clinical trial NCT04417660 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04417660
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-26
- Primary completion
- 2026-12-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.